Robert L. Roe

755 total citations
19 papers, 592 citations indexed

About

Robert L. Roe is a scholar working on Pharmacology, Biological Psychiatry and Rheumatology. According to data from OpenAlex, Robert L. Roe has authored 19 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Biological Psychiatry and 4 papers in Rheumatology. Recurrent topics in Robert L. Roe's work include Tryptophan and brain disorders (4 papers), Schizophrenia research and treatment (4 papers) and Diet and metabolism studies (3 papers). Robert L. Roe is often cited by papers focused on Tryptophan and brain disorders (4 papers), Schizophrenia research and treatment (4 papers) and Diet and metabolism studies (3 papers). Robert L. Roe collaborates with scholars based in United States and Poland. Robert L. Roe's co-authors include Udo Boerner, Seth R. Abbott, Christine Blasey, Joseph K. Belanoff, Thaddeus Block, Coleman Gross, Charles E. Becker, Sydney H. Dromgoole, Daniel E. Furst and Harold E. Paulus and has published in prestigious journals such as Annals of the New York Academy of Sciences, The American Journal of Cardiology and International Journal of Pharmaceutics.

In The Last Decade

Robert L. Roe

19 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert L. Roe United States	11	138	125	114	96	77	19	592
David W. J. Clark New Zealand	17	163 1.2×	145 1.2×	77 0.7×	129 1.3×	31 0.4×	37	944
Ming Lo France	18	109 0.8×	278 2.2×	382 3.4×	63 0.7×	83 1.1×	59	1.3k
P M Kabra United States	20	145 1.1×	125 1.0×	180 1.6×	73 0.8×	56 0.7×	33	1.1k
J.Alan Herd United States	11	35 0.3×	104 0.8×	111 1.0×	28 0.3×	69 0.9×	18	789
Ka Kit Hui United States	13	146 1.1×	214 1.7×	71 0.6×	47 0.5×	19 0.2×	31	655
Scott R. Hamann United States	16	125 0.9×	171 1.4×	84 0.7×	90 0.9×	14 0.2×	37	929
Nevena Divac Serbia	13	83 0.6×	75 0.6×	51 0.4×	47 0.5×	15 0.2×	38	730
Leena Nyman Finland	14	140 1.0×	118 0.9×	49 0.4×	217 2.3×	20 0.3×	24	1.1k
D R Abernethy United States	16	204 1.5×	88 0.7×	37 0.3×	278 2.9×	9 0.1×	31	981
Dale G. Friend United States	14	104 0.8×	71 0.6×	69 0.6×	33 0.3×	18 0.2×	70	779

Countries citing papers authored by Robert L. Roe

Since Specialization

Citations

This map shows the geographic impact of Robert L. Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Roe more than expected).

Fields of papers citing papers by Robert L. Roe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Roe. The network helps show where Robert L. Roe may publish in the future.

Co-authorship network of co-authors of Robert L. Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Roe. A scholar is included among the top collaborators of Robert L. Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Roe. Robert L. Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hunt, Hazel, Nicholas C. Ray, George W. Hynd, et al.. (2012). Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat. Bioorganic & Medicinal Chemistry Letters. 22(24). 7376–7380. 22 indexed citations

Belanoff, Joseph K., Christine Blasey, Robin D. Clark, & Robert L. Roe. (2011). Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats. European Journal of Pharmacology. 655(1-3). 117–120. 6 indexed citations

Blasey, Christine, Thaddeus Block, Joseph K. Belanoff, & Robert L. Roe. (2011). Efficacy and Safety of Mifepristone for the Treatment of Psychotic Depression. Journal of Clinical Psychopharmacology. 31(4). 436–440. 55 indexed citations

Gross, Coleman, Christine Blasey, Robert L. Roe, & Joseph K. Belanoff. (2010). Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men. Obesity. 18(12). 2295–2300. 40 indexed citations

Gross, Coleman, Christine Blasey, Robert L. Roe, et al.. (2009). Mifepristone treatment of olanzapine-induced weight gain in healthy men. Advances in Therapy. 26(10). 959–969. 36 indexed citations

Blasey, Christine, Charles DeBattista, Robert L. Roe, Thaddeus Block, & Joseph K. Belanoff. (2009). A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction. Contemporary Clinical Trials. 30(4). 284–288. 44 indexed citations

Dennish, George W., et al.. (1989). Usefulness of nicardipine as monotherapy for chronic, stable angina. The American Journal of Cardiology. 63(17). 1203–1207. 1 indexed citations

Kamm, Barbara, et al.. (1984). Ticlopidine aspirin stroke study. Controlled Clinical Trials. 5(3). 298–298. 2 indexed citations

Day, Richard O., Daniel E. Furst, Sydney H. Dromgoole, et al.. (1982). Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 31(6). 733–740. 75 indexed citations

10.

Roe, Robert L., et al.. (1981). The Effects Of Ticlopidine Hydrochloride On Bleeding Time And Platelet Function In Man. Thrombosis and Haemostasis. 14 indexed citations

11.

Mroszczak, Edward J., et al.. (1981). Bioavailability and in vitro dissolution of tiopinac from solution and capsule formulations. International Journal of Pharmaceutics. 7(3). 245–260. 1 indexed citations

12.

Roe, Robert L.. (1977). Drug Therapy in Rheumatic Diseases. Medical Clinics of North America. 61(2). 405–418. 4 indexed citations

13.

Becker, Charles E., T G Tong, Udo Boerner, et al.. (1976). Diagnosis and treatment of Amanita phalloides-type mushroom poisoning: use of thioctic acid.. PubMed. 125(2). 100–9. 57 indexed citations

14.

Roe, Robert L.. (1975). The Anti-Inflammatory Agents Used in Rheumatic Disorders. Primary Care Clinics in Office Practice. 2(2). 259–273. 1 indexed citations

15.

Becker, Charles E., et al.. (1975). RATIONAL DRUG THERAPY OF ALCOHOLISM WITH SEDATIVE HYPNOTIC DRUGS! IS THIS POSSIBLE?. Annals of the New York Academy of Sciences. 252(1). 379–384. 2 indexed citations

16.

Boerner, Udo & Robert L. Roe. (1975). The formation of norcodeine from morphine in man. Journal of Pharmacy and Pharmacology. 27(3). 215–216. 3 indexed citations

17.

Fye, Kenneth H., Richard P. Jacobs, & Robert L. Roe. (1975). Vascular manifestations of von Recklinghausen's disease.. PubMed. 122(2). 110–6. 24 indexed citations

18.

Boerner, Udo, Seth R. Abbott, & Robert L. Roe. (1975). The Metabolism of Morphine and Heroin in Man. Drug Metabolism Reviews. 4(1). 39–73. 184 indexed citations

19.

Boerner, Udo, Robert L. Roe, & Charles E. Becker. (1974). Detection, isolation and characterization of normorphine and norcodeine as morphine metabolites in man. Journal of Pharmacy and Pharmacology. 26(6). 393–398. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact